← Open Payments lookup

EDWARD AVILES: Open Payments

NPI 1972199347 · KANSAS CITY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,807 in 124 payments from 11 companies in 2025. Trend: 2023 $1,212 · 2024 $1,064 · 2025 $1,807

Food & beverage: $1,707Education: $100
CompanyPaymentsAmount
ABBVIE INC.31$416
Otsuka America Pharmaceutical, Inc.26$322
E.R. Squibb & Sons, L.L.C.20$236
Alkermes, Inc.12$229
Teva Pharmaceuticals USA, Inc.13$216
Neurocrine BioSciences, Inc.11$178
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$78
Vanda Pharmaceuticals Inc.2$49
Axsome Therapeutics, Inc.2$37
Janssen Pharmaceuticals, Inc2$33

Products named: VRAYLAR, COBENFY, ARISTADA, REXULTI, INGREZZA, ABILIFY ASIMTUFII, AUSTEDO XR, CAPLYTA.

Industry payments across MO — which companies pay providers there.